The overall goal of this study is to answer specific questions about the natural history of brittle bone diseases as defined by molecular etiology and to develop the foundation for prospective clinical studies.
Study Details
Internal Title:
22-091 - Longitudinal OI
PCH IRB Number:
S-IRB-22-091
Clinical Trials Government Identifier:
NCT02432625
Diagnoses & Treatments:
Osteogenesis Imperfecta, OI, Brittle Bone Disease
Study Type:
Other
Eligibility:
Individuals with OI diagnosed by molecular (DNA) analysis OR Individuals whose clinical history and radiographs are highly suggestive of OI, but whose diagnosis has not been verified by biochemical or molecular studies
Enrollment Status:
Open
Phase:
Other